Further studies are needed to explore the correlation of GTF2F2 with immune response pathways such as the JAK-STAT and PI3K-Akt pathways and with inflammatory factors, which may improve the treatment of patients with depression. The gene discussed is AKT1; the disease is major depressive disorder.